CV – Faiçal JARRAYA

Born on Feb 18,1967, in Sfax
Office 00 33 4 81828102, Secretary 00 33 4 81828100 extension 8110,
Mob. 00 7 82863889
Whatsapp 0033782863889
Email jarraya_faical@yahoo.fr
https://orcid.org/0000-0002-3619-3823

Graduated from the Faculty of Medicine Sfax (FMS), University of Sfax, Tunisia-1994; He earned
degrees academics from the Universities of Amiens, Paris V and Lille; License and Research Master
from the University of Grenoble, France. He is a professor at Faculty of Medicine Sfax and a
nephrologist at the Sfax University Hospital, currently at AGDUC (Association Grenobloise de Dialyse
des Urémiques Chroniques), Montelimar, France. He is an ESH-certified clinical hypertension
specialist (2009) and FERA-Fellow of the European Renal Association (2016). He coordinates the
professional master of hypertension organized by FMS and the continuing medical education
program HTAcademy. He is researcher, former head of research unit 12ES14. He was president of the
Association for the development of medical research, Tunisia. He is an elected member and deputy
General Secretary of AFRAN African Association of Nephrology, webmaster of its website and chair of
the AFRAN web and media committee. He is member of the ISN-Africa Board and former member of
Tunisian Society of Nephrology (general secretary), Francophone Society of nephrology board, ISN
Renal Sister Centers committee and ERA-EDTA registry committee. He is current member of the
scientific committee of the SFHTA, French Society of Hypertension; ESH Hypertension and kidney
working group and SFNDT Committee on humanitarian nephrology research. He is member of several
international societies, including SFNDT, SFHTA, ISN, ERA-EDTA, ISH and ESH. Dr Jarraya was invited
to give lectures in meetings of national, African and international societies including ISN, ERA EDTA,
ESH, ISHD, SFHTA, AFRAN. He has co-authored more than 75 articles in indexed journals and books
chapters (jarraya f – Search Results – PubMed (nih.gov)). His area of interest includes hypertension,
diabetic nephropathy, primary hyperoxaluria, dialysis and CV and renal prevention.